Intra Gel
Nazareth, IL · 1 known investors
Find your way into Intra Gel
Sign up to see every warm intro you have to Intra Gel
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intra Gel team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intragel is developing SRGel, a solvent-free long-acting injectable (LAI) drug delivery platform designed to enable controlled, extended release from a single injection for small molecules, peptides and biologics. The platform aims to extend dosing intervals and reduce injection frequency across multiple therapeutic areas.
Founders & leadership
PS
Peter SimanCEO & Co-founderPeter Siman holds a Ph.D. in chemistry from Ben-Gurion University of the Negev and undergraduate and master's degrees from Hebrew University of Jerusalem; he conducted postdoctoral research in reticular chemistry at UC Berkeley from 2013–2015 and is co-founder and CEO of IntraGel Therapeutics, which develops long-acting injectable drug delivery platforms for oncology and other therapeutic areas.
Investors · 1
Frequently asked questions
- What does Intra Gel do?
- Intragel is developing SRGel, a solvent-free long-acting injectable (LAI) drug delivery platform designed to enable controlled, extended release from a single injection for small molecules, peptides and biologics. The platform aims to extend dosing intervals and reduce injection frequency across multiple therapeutic areas.
- Who founded Intra Gel?
- Intra Gel was founded by Peter Siman.
- Who are Intra Gel's investors?
- Intra Gel's investors include NGT Healthcare 2.
- Where is Intra Gel headquartered?
- Intra Gel is headquartered in Nazareth, IL.
